http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2009221091-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19229fe7f5fcc0a484adc464fc5bdb8d |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 |
filingDate | 2009-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0df8b51c33d01a1a278aad5c0b14578 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f6a2bdc01b581a17426afc2c7a8ea5f |
publicationDate | 2013-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2009221091-B2 |
titleOfInvention | Process for preparing enantiomerically pure indolopyridines |
abstract | The invention relates to a novel process for the preparation of pharmacologically interesting indolopyridine derivatives containing tetracyclic tetrahydro-β-carboline-hydantoines linked to a basic side chain and the corresponding salts, which can be used as Eg5 inhibitor, with very high overall chemical yield and enantiomeric purity. |
priorityDate | 2008-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 242.